Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

There is modest evidence that systemic acyclovir or valacyclovir prevents recurrent herpes labialis.

There is modest evidence that systemic acyclovir or valacyclovir prevents recurrent herpes labialis. J Evid Based Dent Pract. 2013 Mar; 13(1):16-7.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.